Skip to main content
. 2003 May 1;111(9):1329–1338. doi: 10.1172/JCI16750

Figure 4.

Figure 4

DALDA administered in treatment mode improves the macroscopic and histologic lesions. (a and b) The anti-inflammatory effects of DALDA (10–2 mg/kg/d) administered in treatment mode (after colitis induction) were assessed 2 days (D2) and 4 days (D4) after TNBS administration. The severity of the lesions was evaluated using the macroscopic and histologic scores of Wallace (a) and Ameho (b), respectively. The number of mice and statistical significance are indicated and results are expressed as the mean ± SEM.